Therapy with DAAs in patients with chronic hepatitis C and advanced chronic kidney disease: Real-world experience of the German Hepatitis C Registry

2018 ◽  
Vol 56 (01) ◽  
pp. E2-E89
Author(s):  
J Wiegand ◽  
P Buggisch ◽  
S Mauss ◽  
K Böker ◽  
H Klinker ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Advanced Chronic Kidney Disease

Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease

2018 ◽  
Vol 159 ◽  
pp. 143-152 ◽  
Author(s):  
Eiichi Ogawa ◽  
Norihiro Furusyo ◽  
Koichi Azuma ◽  
Makoto Nakamuta ◽  
Hideyuki Nomura ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Cohort Study ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Genotype 1

Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease

2016 ◽  
Vol 21 (5) ◽  
pp. 818-824 ◽  
Author(s):  
Norihiko Morisawa ◽  
Yohei Koshima ◽  
Jun-ichi Satoh ◽  
Yukio Maruyama ◽  
Satoru Kuriyama ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Chronic Hepatitis C Patients
Sign in / Sign up

Export Citation Format

Share Document